A CIRCULATING EXOSOMAL MICRORNA SIGNATURE FOR THE NONINVASIVE PREDICTION OF RESPONSE TO THE FIRST-LINE PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH METASTATIC GASTRIC CANCER

被引：0
|
作者：
Okuno, Keisuke
Watanabe, Shuichi
Hur, Hoon
Lee, Jeeyun
Tokunaga, Masanori
Kinugasa, Yusuke
Goel, Ajay
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1125
引用
收藏
页码：S766 / S766
页数：1
相关论文
共 50 条
  • [21] Impact of the objective response to and number of cycles of platinum-based first-line chemotherapy for metastatic urothelial carcinoma on overall survival of patients treated with pembrolizumab
    Kato, Minoru
    Kobayashi, Takashi
    Matsui, Yoshiyuki
    Ito, Katsuhiro
    Hikami, Kensuke
    Yamada, Takeshi
    Ogawa, Kosuke
    Nakamura, Kenji
    Sassa, Naoto
    Yokomizo, Akira
    Abe, Takashige
    Tsuchihashi, Kazunari
    Tatarano, Shuichi
    Inokuchi, Junichi
    Tomida, Ryotaro
    Fujiwara, Maki
    Takahashi, Atsushi
    Matsumoto, Kazumasa
    Shimizu, Kosuke
    Araki, Hiromasa
    Kurahashi, Ryoma
    Ozaki, Yu
    Tashiro, Yu
    Uegaki, Masayuki
    Kojima, Takahiro
    Uchida, Junji
    Ogawa, Osamu
    Nishiyama, Hiroyuki
    Kitamura, Hiroshi
    INTERNATIONAL JOURNAL OF UROLOGY, 2021, 28 (12) : 1261 - 1267
  • [22] Chemotherapy Toxicity in BRCA Mutation Carriers Undergoing First-Line Platinum-Based Chemotherapy
    Weitzner, Omar
    Yagur, Yael
    Kadan, Yfat
    Beiner, Mario E.
    Fishman, Ami
    Ben Ezry, Emilie
    Komem, Daphna Amitai
    Helpman, Limor
    ONCOLOGIST, 2019, 24 (12): : E1471 - E1475
  • [23] Impact of bone metastasis on clinical outcomes in metastatic urothelial bladder cancer (mUC) for patients treated with first-line platinum-based chemotherapy.
    Riromar, Jamila Jama Almi
    Veitch, Zachary William Neil
    Sacher, Adrian G.
    Maganti, Manjula
    Fallah-Rad, Nazanin
    Hansen, Aaron Richard
    Sridhar, Srikala S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [24] Circulating Exosomal MicroRNA Signature Predicts Peritoneal Metastasis in Patients with Advanced Gastric Cancer
    Wada, Yuma
    Nishi, Masaaki
    Yoshikawa, Kozo
    Takasu, Chie
    Tokunaga, Takuya
    Nakao, Toshihiro
    Kashihara, Hideya
    Yoshimoto, Toshiaki
    Shimada, Mitsuo
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (09) : 5997 - 6006
  • [25] Platinum-based combinations as first-line chemotherapy in advanced, persistent, or recurrent cervical cancer.
    Limareva, Svetlana Vladimirovna
    Khokhlova, Svetlana Victorovna
    Odintsova, Anastasiya Sergeevna
    Cherkasova, Marina Valerievna
    Vinogradova, Liliya Igorevna
    Gorbunova, Vera A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [26] THE EFFECTS OF PLATINUM-BASED CHEMOTHERAPY RECHALLENGE FOR ADVANCED UROTHELIAL CARCINOMA PATIENTS WHOSE DISEASE PROGRESSED AFTER FIRST-LINE PLATINUM-BASED CHEMOTHERAPY AND PEMBROLIZUMAB
    Yumioka, Tetsuya
    Honda, Masashi
    Shimizu, Ryutaro
    Teraoka, Shogo
    Kimura, Yusuke
    Iwamoto, Hideto
    Morizane, Shuichi
    Hikita, Katsuya
    Takenaka, Atsushi
    JOURNAL OF UROLOGY, 2021, 206 : E1001 - E1002
  • [27] A two-microRNA-based signature predicts first-line chemotherapy outcomes in advanced colorectal cancer patients
    Jia-huan Lu
    Zhi-xiang Zuo
    Wei Wang
    Qi Zhao
    Miao-zhen Qiu
    Hui-yan Luo
    Zhan-hong Chen
    Hai-yu Mo
    Feng Wang
    Dong-dong Yang
    Yun Wang
    Xiao-li Wei
    Qi-nian Wu
    Huai-qiang Ju
    Rui-hua Xu
    Zhao-lei Zeng
    Cell Death Discovery, 4
  • [28] A two-microRNA-based signature predicts first-line chemotherapy outcomes in advanced colorectal cancer patients
    Lu, Jia-huan
    Zuo, Zhi-xiang
    Wang, Wei
    Zhao, Qi
    Qiu, Miao-zhen
    Luo, Hui-yan
    Chen, Zhan-hong
    Mo, Hai-yu
    Wang, Feng
    Yang, Dong-dong
    Wang, Yun
    Wei, Xiao-li
    Wu, Qi-nian
    Ju, Huai-diang
    Xu, Rui-hua
    Zeng, Zhao-lei
    CELL DEATH DISCOVERY, 2018, 4
  • [29] Cost-Effectiveness of Adding Cetuximab to Platinum-Based Chemotherapy for First-Line Treatment of Recurrent or Metastatic Head and Neck Cancer
    Hannouf, Malek B.
    Sehgal, Chander
    Cao, Jeffrey Q.
    Mocanu, Joseph D.
    Winquist, Eric
    Zaric, Gregory S.
    PLOS ONE, 2012, 7 (06):
  • [30] Clinical outcomes for advanced thymoma patients receiving platinum-based chemotherapy as first-line treatment
    Hao, Y.
    Sun, W.
    Zeng, X.
    Shi, Z.
    Wang, W.
    Xu, C.
    Song, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S157 - S157
12345